New Genmab Darzalex drug results seen increase sales

COPENHAGEN (Reuters) - Danish biotech Genmab, which has seen its shares rocket 163 percent this year, is set for further gains as new research data showed increased potential for its Darzalex blood cancer treatment, analysts said on Wednesday.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro